has reported Standalone financial results for the period ended September 30, 2022.
Financial Results (Q2 FY2023) - QoQ Comparison
The company has reported total income of Rs. 21.7704 crores during the period ended September 30, 2022 as compared to Rs. 20.6132 crores during the period ended June 30, 2022.
The company has posted net profit / (loss) of Rs. 1.2001 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs. 1.1484 crores for the period ended June 30, 2022.
The company has reported EPS of Rs. 0.03 for the period ended September 30, 2022 as compared to Rs. 0.03 for the period ended June 30, 2022.
Total Income | ₹ 21.7704 crs | ₹20.6132 crs | 5.61% |
Net Profit | ₹1.2001 crs | ₹1.1484 crs | 4.50% |
EPS | ₹0.03 | ₹0.03 | 0.00% |
Financial Results (Q2 FY2023) - YoY Comparison The company has reported total income of Rs. 21.7704 crores during the period ended September 30, 2022 as compared to Rs.17.9618 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.1.2001 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs.0.8241 crores for the period ended September 30, 2021.
The company has reported EPS of Rs.0.03 for the period ended September 30, 2022 as compared to Rs..41 for the period ended September 30, 2021.
Total Income | ₹ 21.7704 crs | ₹17.9618 crs | 21.20% |
Net Profit | ₹1.2001 crs | ₹0.8241 crs | 45.63% |
EPS | ₹0.03 | ₹.41 | -92.68% |
Financial Results (Half Year Ended FY2023) - YoY Comparison The company has reported total income of Rs.42.3836 crores during the 6 Months period ended September 30, 2022 as compared to Rs.33.5243 crores during the 6 Months period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.2.3485 crores for the 6 Months period ended September 30, 2022 as against net profit / (loss) of Rs.1.5063 crores for the 6 Months period ended September 30, 2021.
The company has reported EPS of Rs..06 for the 6 Months period ended September 30, 2022 as compared to Rs.0.76 for the 6 Months period ended September 30, 2021.
Total Income | ₹42.3836 crs | ₹33.5243 crs | 26.43% |
Net Profit | ₹2.3485 crs | ₹1.5063 crs | 55.91% |
EPS | ₹.06 | ₹0.76 | -92.11% |
Source : Equity Bulls
Keywords
ShreeGaneshBiotechIndia
Q2FY23
H1FY23
ResultUpdate